ES8600733A1 - Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico - Google Patents

Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico

Info

Publication number
ES8600733A1
ES8600733A1 ES527289A ES527289A ES8600733A1 ES 8600733 A1 ES8600733 A1 ES 8600733A1 ES 527289 A ES527289 A ES 527289A ES 527289 A ES527289 A ES 527289A ES 8600733 A1 ES8600733 A1 ES 8600733A1
Authority
ES
Spain
Prior art keywords
powder
grout
preparation
absorbable
aminocaproic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527289A
Other languages
English (en)
Other versions
ES527289A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Pharmaceutical Partners
Original Assignee
Serono Pharmaceutical Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Pharmaceutical Partners filed Critical Serono Pharmaceutical Partners
Publication of ES8600733A1 publication Critical patent/ES8600733A1/es
Publication of ES527289A0 publication Critical patent/ES527289A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA MEZCLA LIOFILIZADA DE POLVO ABSORBIBLE Y ACIDO AMINOCAPROICO.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE MEZCLA POLVO DE GELATINA ABSORBIBLE, ACIDO AMINOCAPROICO Y AGUA PARA FORMAR UNA LECHADA; SEGUNDA, SE INTRODUCE UNA PARTE ALICUOTA DE LA LECHADA EN UNA JERINGUILLA; Y POR ULTIMO, SE LIOFILIZA LA LECHADA EN LA JERINGUILLA. EL POLVO DE GELATINA ABSORBIBLE CONSTITUYE APROXIMADAMENTE ENTRE UN 20 Y UN 90 DE LA MEZCLA DE DICHO POLVO Y ACIDO AMINOCAPROICO.DE APLICACION EN LA CORRECCION DE CICATRICES CUTANEAS LINEALES Y OVOIDALES CON DEPRESION.
ES527289A 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico Granted ES527289A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/442,151 US4540410A (en) 1982-11-16 1982-11-16 Lyophilized compositions, preparation and use thereof

Publications (2)

Publication Number Publication Date
ES8600733A1 true ES8600733A1 (es) 1985-11-01
ES527289A0 ES527289A0 (es) 1985-11-01

Family

ID=23755732

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527289A Granted ES527289A0 (es) 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico
ES546583A Expired ES8706312A1 (es) 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES546583A Expired ES8706312A1 (es) 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Country Status (12)

Country Link
US (1) US4540410A (es)
EP (1) EP0109188B1 (es)
AT (1) ATE24838T1 (es)
AU (1) AU558164B2 (es)
CA (1) CA1228542A (es)
DE (1) DE3369070D1 (es)
DK (1) DK164538C (es)
ES (2) ES527289A0 (es)
IL (1) IL69923A (es)
NO (1) NO165625C (es)
PT (1) PT77621B (es)
ZA (1) ZA837407B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4743229A (en) * 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
DE3816961A1 (de) * 1987-07-21 1989-02-02 Wasserburger Arzneimittelwerk Injektionsspritze fuer medizinische zwecke
EP0365704A1 (de) * 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopräparat für Hämostase bei Magenblutungen
US5063178A (en) * 1990-03-19 1991-11-05 Medex, Inc. Freeze-dried blood gas sensor
FR2694496A1 (fr) * 1992-08-05 1994-02-11 Bernstein Serge Procédé pour l'obtention d'un produit permettant l'expansion des seins et le traitement des rides.
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7871637B2 (en) * 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6527738B1 (en) * 1999-04-30 2003-03-04 Prismedical Corporation Drug delivery pack
US20010037091A1 (en) * 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7101354B2 (en) 2004-05-03 2006-09-05 Infusive Technologies, Llc Mixing syringe with and without flush
US7998106B2 (en) 2004-05-03 2011-08-16 Thorne Jr Gale H Safety dispensing system for hazardous substances
BRPI0712088B8 (pt) * 2006-05-31 2021-06-22 Baxter Healthcare Sa uso de uma biomatriz de lâmina de colágeno de múltiplas camadas microscópicas não porosa e hermética a fluido
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
AR069109A1 (es) 2007-10-30 2009-12-30 Baxter Int Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
DK2442835T3 (en) 2009-06-16 2015-03-16 Baxter Int Styptic sponge
BR112012014773A2 (pt) 2009-12-16 2015-11-03 Baxter Healthcare Sa esponja de compósito hemostática, método para fabricar uma esponja de compósito hemostática, e, uso da referida esponja
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
MX352875B (es) * 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
CA2801118C (en) * 2010-06-01 2016-01-05 Baxter International Inc. Process for making dry and stable hemostatic compositions
AU2011260258B2 (en) 2010-06-01 2015-07-09 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
HK1201212A1 (en) 2011-10-11 2015-08-28 Baxter International Inc Hemostatic compositions
CA2851321C (en) 2011-10-11 2020-07-07 Baxter International Inc. Hemostatic compositions
ES2553702T3 (es) 2011-10-27 2015-12-11 Baxter International Inc Composiciones hemostáticas
JP6241624B2 (ja) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス 止血ペーストを収容する加圧容器
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス 止血および創傷治癒に使用するための乾燥組成物
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN112368028A (zh) 2018-05-09 2021-02-12 弗罗桑医疗设备公司 用于制备止血组合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB450145A (en) * 1934-01-13 1936-07-06 Sharp & Dohme Inc Lyophilic biologically active substances and process of producing the same
GB455027A (en) * 1935-01-04 1935-08-01 Sharp & Dohme Inc Normal serum product and process of producing the same
US2380339A (en) * 1941-07-10 1945-07-10 Fromm Lab Inc Method and apparatus for preserving biological substances
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4191751A (en) * 1975-06-04 1980-03-04 Gottlieb Sheldon K Method for promoting growth of new connective tissue over surface wounds
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue

Also Published As

Publication number Publication date
NO834183L (no) 1984-05-18
NO165625C (no) 1991-03-13
AU558164B2 (en) 1987-01-22
DK164538C (da) 1993-01-11
DK521283D0 (da) 1983-11-15
US4540410A (en) 1985-09-10
PT77621B (en) 1986-03-19
ES8706312A1 (es) 1987-07-01
EP0109188B1 (en) 1987-01-14
DK521283A (da) 1984-05-17
EP0109188A1 (en) 1984-05-23
ES546583A0 (es) 1987-07-01
PT77621A (en) 1983-12-01
ZA837407B (en) 1985-05-29
ATE24838T1 (de) 1987-01-15
IL69923A (en) 1987-03-31
DE3369070D1 (en) 1987-02-19
DK164538B (da) 1992-07-13
AU2091683A (en) 1984-05-24
NO165625B (no) 1990-12-03
CA1228542A (en) 1987-10-27
ES527289A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
DK164538C (da) Middel til kosmetisk hudpleje og fremgangsmaade til dets fremstilling
NZ183931A (en) Polypeptide analogues of luteinising harmone releasing factor (lh-rf);pharmaceutical veterinary compositions
ES8307845A1 (es) Procedimiento para preparar una polilactida.
DK581185A (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES546840A0 (es) Un procedimiento para preparar una sal de acido n-acetil- neuraminico
NZ191630A (en) Medicated animal feeds containing liver meal
UA6028A1 (uk) Спосіб одержання біологічно активної композиції
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
IT1116840B (it) Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
ES524408A0 (es) Procedimiento para la preparacion de acido 3b-(3-carboxipropioniloxi)-ursa-9(11),12-dien-28-oico
SE8701787L (sv) Sukralfat beredning och forfarande for framstellning av densamma
JPS52145528A (en) Preparation of gel composition for nail enamel
JPS56125312A (en) Remedy for damage
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5441321A (en) Remedy for skin diseases and its preparation
JPS5272812A (en) Preparation of cephatridin pharmaceuticals for rectal infusion
GB942743A (en) Oestrogen preparations and the manufacture thereof
GT197120675A (es) Composiciones terapeuticas.
UA5586A1 (uk) Інсектицидний засіб
SU1450438A1 (ru) Состав для полирования монокристаллов
ES8401775A3 (es) "procedimiento para la obtencion de levadura en polvo de estabilidad mejorada".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519